TCF-1+ progenitor exhausted T cells maintain effector function, have high proliferative capability and respond to immune checkpoint blockade (ICB) therapy in cancer (43–45), while TOX is sustainably upregulated during T cell exhaustion, and is involved in epigenetic remodeling and transcriptional programming of exhausted CD8+ T cells (46, 47). This evidence concerns the gene TCF7 and cancer.